Molecular Fingerprint Predicts Flu Shot Response

A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show.

Written byJyoti Madhusoodanan
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, NIAIDGetting a seasonal flu shot can leave healthy adults with the common side effects of feeling achy or feverish. Now, researchers have identified a gene-expression pattern in circulating immune cells that could help predict which individuals are more likely to suffer these adverse effects following vaccination. This molecular signature was also correlated with a person’s chances of having autoreactive antibodies, according to the results published today (January 4) in Nature Immunology.

“Man flu,” a disparaging term for one’s exaggeration of flu-like symptoms, “is partly a joke and it’s partly real. Our study shows that there are very good reasons for people feeling unwell after a vaccination,” said study coauthor Adrian Hayday of King’s College London. “The gene signature in the peripheral blood . . . is not a smoking gun at this point, but it’s a strong association and quite compelling.”

Previous studies have identified reasons why some people fail to respond to flu vaccines while others do, but few have analyzed the molecular correlates of adverse responses.

To identify this unique gene-expression pattern, Hayday and his colleagues began by observing changes in the immune system in response to a vaccine against the H1N1 influenza strain ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies